Advertisement

Gerontology pp 270-277 | Cite as

Altered Response to Benzodiazepines in the Elderly

  • U. Klotz
Conference paper

Abstract

In the Federal Republic of Germany the elderly (defined as subjects over 65 years of age) constitute about 15% of the general population and they consume more than 30% of all drugs (WHO 1985). Benzodiazepines (BZDs) are among the most widely used drugs in the elderly and this population at risk demonstrates an approximately two- to threefold higher incidence of side-effects to various BZDs (for review see Klotz 1986). The increased frequency of adverse reactions to BZDs in the elderly has stimulated basic and clinical research in investigating the mechanism(s) of altered drug response with age. Several studies have evaluated the clinically important problem by a combined pharmacokinetic and pharmacodynamic approach. In general, age-dependent alterations could occur at different levels (see Fig. 1).

Keywords

Endogenous Ligand Altered Response Digit Symbol Substitution Test Pharmacokinetic Change Paradoxical Reaction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alho H, Costa E, Ferrero P, Fujimoto M, Consenza-Morphy D, Guidotti A., (1985) Diazepam- binding inhibitor: a neuropeptide located in selected neuronal populations of rat brain. Science 229: 179–182PubMedCrossRefGoogle Scholar
  2. Bell GD, Spickett GP, Reeve PA, Morden A, Logan RFA., (1987) Intravenous midazolam for upper gastrointestinal endoscopy: a study of 800 consecutive cases relating dose to age and sex of patient. Br J Clin Pharmacol 23: 241–243PubMedGoogle Scholar
  3. Castleden CM, George CF, Marcer D, Hallett C., (1977) Increased sensitivity to nitrazepam in old age. Br Med J I: 10–12Google Scholar
  4. Castleden CM, Allen JG, Altman J, John-Smith P St., (1987) A comparison of oral midazolamGoogle Scholar
  5. nitrazepam and placebo in young and elderly subjects. Eur J Clin Pharmacol 32: 253–257Google Scholar
  6. Cook PJ, Huggett A, Graham-Pole R, Savage IT, James IM., (1983) Hypnotic accumulation and hangover in elderly inpatients: a controlled double-blind study of temazepam and nitrazepam. Br Med J 286: 100–102CrossRefGoogle Scholar
  7. Cook PJ, Flanagan R, James IM., (1984) Diazepam tolerance: effect of age, regular sedation, and alcohol. Br Med J 289: 351–353CrossRefGoogle Scholar
  8. Hinrichs JV, Ghoneim MM., (1987) Diazepam, behavior, and aging: increased sensitivity or lower baseline performance? Psychopharmacology 92: 100–105PubMedCrossRefGoogle Scholar
  9. Kanto J, Aaltonen L, Himberg J-J, Hovi-Viander M., (1986) Midazolam as an intravenous induction agent in the elderly: a clinical and pharmacokinetic study. Anesth Analg 65: 15–20PubMedCrossRefGoogle Scholar
  10. Klotz U., (1979) Effect of age on levels of diazepam in plasma and brain of rats. Naunyn-Schmiedebergs Arch Pharmacol 307: 167–169PubMedCrossRefGoogle Scholar
  11. Klotz U., (1986) Age-dependent actions of benzodiazepines. In: Platt D (ed) Drugs and aging, Springer Berlin Heidelberg New York pp 131–139Google Scholar
  12. Klotz U., (1989) Stellen Benzodiazepine »natürliche« Arzneimittel dar? Klin Wochenschr 67: 93–94PubMedCrossRefGoogle Scholar
  13. Komiskey HL., (1987) Aging: effect on ex-vivo benzodiazepine binding after a diazepam injection. Neurochem Res 12: 754–749CrossRefGoogle Scholar
  14. Lamy PP., (1987) Age-associated pharmacodynamic changes. Methods Find Exp Clin Pharmacol 9: 153–159PubMedGoogle Scholar
  15. Memo M, Spano PF, Trabucchi M., (1981) Brain benzodiazepine receptor changes during aging. J Pharm Pharmacol 33: 64PubMedCrossRefGoogle Scholar
  16. Mooradian AD., (1988) Effect of aging on the blood-brain barrier. Neurobiol Aging 9: 31–39PubMedCrossRefGoogle Scholar
  17. Pedigo NW, Schoemaker H, Morelli M, McDougal JN, Malick JB, Burks TF, Yamamura HI., (1981) Benzodiazepine receptor binding in young, mature and senescent rat brain and kidney. Neurobiol Aging 2: 83–88PubMedCrossRefGoogle Scholar
  18. Rahman A, Komiskey HL, Hayton WL, Weisenburger WP., (1986) Aging: changes in distribution of diazepam and metabolites in the rat. Drug Metab Dispos 14: 299–302PubMedGoogle Scholar
  19. Reeves PM, Schweizer MP., (1983) Aging, diazepam exposure and benzodiazepine receptors in rat cortex. Brain Res 270: 376–379PubMedCrossRefGoogle Scholar
  20. Reidenberg MM, Levy M, Warner H, Coutinho CB, Schwartz MA, Yu G, Cheripko J., (1978) Relationship between diazepam dose, plasma level, age, and central nervous system depression. Clin Pharmacol Ther 23: 371–374PubMedGoogle Scholar
  21. Severson JA., (1987) Synaptic regulation of neurotransmitter function in aging. Rev Biol Aging 3: 191–206Google Scholar
  22. Swift CG, Haythorne JM, Clarke P, Stevenson IH., (1981) The effect of aging on measured responses to single doses of oral temazepam. Br J Pharmacol 73: 413P–414 PGoogle Scholar
  23. Swift CG, Ewen JM, Clarke P, Stevenson IH., (1985a) Responsiveness to oral diazepam in the elderly: relationship to total and free plasma concentrations. Br J Clin Pharmacol 20: 111–118PubMedGoogle Scholar
  24. Swift CG, Swift MR, Ankier SI, Pidgen A, Robinson J., (1985b) Single dose pharmacokinetics and pharmacodynamics of oral loprazolam in the elderly. Br J Clin Pharmacol 20: 119–128PubMedGoogle Scholar
  25. Tsang C-FC, Wilkinson GR., (1982) Diazepam disposition in mature and aged rabbits and rats. Drug Metab Dispos 10: 413–416PubMedGoogle Scholar
  26. Tsang CC, Speeg Jr KV, Wilkonson GR., (1982) Aging and benzodiazepine binding in the rat cerebral cortex. Life Sci 30: 343–346PubMedCrossRefGoogle Scholar
  27. WHO Regional Office for Europe (1985) Drugs for the elderly. Copenhagen Yamasaki T, Inoue O, Shinotoh H., (1986) Benzodiazepine receptor study in the elderly using PET and clinical application of a new tracer, C-11-α-methyl-N-methylbenzylamine. In: Kitani K (ed) Liver and aging - 1986, liver and brain, Elsevier Scientific Amsterdam, pp 265–276Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • U. Klotz
    • 1
  1. 1.Dr. Margarete Fischer-Bosch-Institut für Klinische PharmakologieStuttgart 50Germany

Personalised recommendations